knowledge -WSS

knowledge

author：entertainment 2025-08-11 11:45:38 - browse：9478

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

WSS

House panel to mark up pandemic

Resistance to opioid

Study gives hint on South Asians’ higher risk of cardiovascular disease

STAT Boddities: What happens to the brain when we get scared?

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Ebola vaccine can save some who are already sick, per new study

Wikipedia

knowledge

hotspot

Sports medicine is finally prioritizing gender equality

Neutralizing antibodies against HIV shows promise in children

In Memoriam: Notable people who died in 2023

Rare Northern Lights show in US this week: Where and how to see it

Medicare details structure of new drug price negotiation program

Congress might make insulin pumps more accessible to the blind

The cancer drug shortage isn’t new — and neither are the solutions

Latigo launches with $135 million for Vertex

Dobbs anniversary: the lost opportunity of abortion as health care

Another man arrested in connection with shooting at Kansas nightclub

knowledge

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Drinking water from half of US faucets contains PFAS: Study

Juul documents reveal insider tactics on political lobbying

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Congress might make insulin pumps more accessible to the blind

Websites selling Wegovy, Zepbound ingredients targeted by FDA

knowledge

hotspot

hotspot

explore